Today, neonatal tetanus accounts for a significant portion of newborn and under−5 mortality – 40% and 57%, respectively – and is the most prevalent cause of neonatal mortality and morbidity, particularly in developing nations. As a result, more study on birth protection against neonatal tetanus is required because it is such a terrible condition with such a high death rate and there is a need for more recent evidence on it. From April 1 to 30, 2022, a community-based cross-sectional survey was carried out in the Gozamn district of Northwest Ethiopia. A two-stage stratified sampling procedure was applied, with an overall sample size of 831. The data were gathered using a pre-tested, structured questionnaire. It was then checked, cleaned, and entered into Epidata software version 4.6 before being exported to Stata version 14 for analysis. The proportions of birth protected against neonatal tetanus were 58.57% (95% CI (55.15–61.89%) in the study. Mother who had radio (AOR = 3.09,95%CI: 2.09, 4.56), mother who travel less than one hour to reach nearest health facility (AOR = 1.96,95%CI: 1.23,3.10), mother who gave birth of their last child in the health institution (AOR = 4.17,95%CI:2.39,7.28), mothers who had information from health professional (AOR = 2.56,95%CI:1.56,4.19) and > 4 ANC visit (AOR = 2.57,95%CI:1.55,4.26) were positive predictors of birth protected against neonatal tetanus. Low levels of maternal protection against neonatal tetanus were seen in this study location. To enhance the percentage of births protected against neonatal tetanus, professional-based guidance regarding the TT vaccine are essential.
Background: Unintended pregnancy is a pregnancy that is untimely or unforeseen at the time of conception but may be wanted later.The burden and negative consequences of unintended pregnacy is miserable if it happens among HIV positive women.There was a paucity of evidence regarding unintended pregnancy among HIV positive women in the study area. Objective:- To assess the prevalence and factor associated with unintended pregnancy among pregnant women living with HIV in Bahirdar town health care facilities 2022. Methods:- An institution-based cross-sectional study was conducted from February 1st to march 30th 2022..A systematic sampling technique was employed to select 408 eligible women. A structured, pretested interview administered questionnaire and chart review was used to collect the data. Data were entered in to Epidata version 4.6 and exported to SPSS version 23 for data analysis. Multivariable logistic regression model fitted to identify factors associated with unintended pregnancy.Statical association was claimed based on the adjusted odds ratio (AOR) with its 95% CI and a p-value of ≤ 0.05. Result :- Prevalence of unintended pregnancy among HIV positive pregnant women in Bahirdar town public health facilities was (22.4 %) with 95% CI=18.2- 26.4).Factors significantly associated with unintended pregnancy were, who doesn’t want more child [AOR:4.24,95%CI= 2.31-7.77], who don’t know about dual method [AOR:2.49,95%CI= 1.44-4.30] women taking ARV for more than five years [AOR:2.29,95%CI =1.32-3.95] and having non-regular sexual partner [AOR:0.30,95%CI=0.12-0.70) were significantly associated with unintended pregnancy. Conclusion and recommendation:-Prevalence of unintended pregnancy among PWLHIV in Bahirdar town public health facilities was slightly less than the global unintended pregnancy prevalence. Better to give counselling on use of dual method and to practice safe sexual practice thereby decrease unintended pregnancy and reinfection with new virus.
Introduction: An estimated 3.3 million newborn deaths occur each year around the world, with 9,000 babies dying every day in their first 28 days. Neonatal tetanus is tetanus that occurs within the first 28 days of life, and maternal immunization can reduce neonatal tetanus by 94%. However, not enough mothers were vaccinated to protect against neonatal tetanus globally, and only 49% of mothers in Ethiopia were protected. The proportion of mothers who were protected from neonatal tetanus was not determined yet in the study area. Because neonatal tetanus is such a serious disorder with such a high fatality rate and there is a need for more recent evidence on it, more research on birth protection against neonatal tetanus is needed. Objective To assess the proportion of births protected against neonatal tetanus and its associated factors among mothers who gave birth within the past 6 months in Gozamn district, Northwest Ethiopia, 2022. Method A community-based cross-sectional study was conducted in the Gozamn district, Northwest Ethiopia from April 1–30, 2022. A total sample size of 831 was used, and a two-stage stratified sampling technique was used. A structured and pre-tested questionnaire was used to collect the data, and the data was analysed by using StataV14. A logistic regression analysis was conducted, and the level of statistical significance was determined by a p-value of less than 0.05. Result The proportions of birth protected against neonatal tetanus were 58.57% in the study. Mother who had radio (AOR = 3.09,95%CI: 2.09, 4.56), mother who travel less than one hour to reach nearest health facility (AOR = 1.96,95%CI: 1.23,3.10), mother who gave birth of their last child in the health institution (AOR = 4.17,95%CI:2.39,7.28), mothers who had information from health professional (AOR = 2.56,95%CI:1.56,4.19) and > 4 ANC visit (AOR = 2.57,95%CI:1.55,4.26) were positive predictors of birth protected against neonatal tetanus. Conclusion In this study area, the proportion of mothers protected against neonatal tetanus was low. Professional based counselling related to TT vaccine, as well as interlinks and strength of different health care services such as ANC and delivery services are vital to increase proportion of birth protected against neonatal tetanus.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.